Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Buy
712,124
+101,465
+17% +$143K 0.02% 473
2026
Q1
$910K Buy
+610,659
New +$928K 0.03% 435
2025
Q3
Sell
-86,398
Closed -$122K 519
2025
Q2
$122K Hold
86,398
﹤0.01% 424
2025
Q1
$137K Sell
86,398
-1,583,286
-95% -$3.86M ﹤0.01% 441
2024
Q4
$5.91M Buy
1,669,684
+1,493,445
+847% +$5.97M 0.15% 185
2024
Q3
$800K Buy
176,239
+135,739
+335% +$617K 0.02% 311
2024
Q2
$172K Sell
40,500
-220,897
-85% -$861K ﹤0.01% 406
2024
Q1
$863K Buy
+261,397
New +$586K 0.03% 281

Other funds holding GERN

J. Goldman & Co's GERN Position: Q2 2026 in Review

J. Goldman & Co increased its Geron (GERN) stake by 17% in Q2 2026, buying an estimated $143K and bringing the position to 712,124 shares worth $912K. The position accounts for 0.02% of the portfolio, ranked #473.

J. Goldman & Co first reported a position in GERN in Q1 2024 and has held it in 8 quarters since. The position peaked at $5.91M in Q4 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • J. Goldman & Co held 712,124 shares of Geron worth $912K as of Q2 2026.
  • J. Goldman & Co bought 101,465 Geron shares in Q2 2026, an estimated $143K.
  • Geron made up 0.02% of J. Goldman & Co's portfolio in Q2 2026, its #473 holding.
  • J. Goldman & Co first reported a position in Geron in Q1 2024 and has held it in 8 quarters since.
  • J. Goldman & Co's Geron position peaked at $5.91M in Q4 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.